SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
(Amendment No. __)
Filed by the Registrant [ ]
Filed by a Party other than the Registrant [X]
Check the appropriate box:
[ ] Preliminary Proxy Statement
[ ] Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
[ ] Definitive Proxy Statement
[X] Definitive Additional Materials
[ ] Soliciting Material Pursuant to 240.14a-12
Forest Laboratories, Inc.
(Name of Registrant as Specified In Its Charter)
Carl C. Icahn
Dr. Alexander J. Denner
Dr. Richard Mulligan
Professor Lucian A. Bebchuk
Dr. Eric J. Ende
Mayu Sris
Icahn Partners LP
Icahn Partners Master Fund LP
Icahn Partners Master Fund II L.P.
Icahn Partners Master Fund III L.P.
High River Limited Partnership
Hopper Investments LLC
Barberry Corp.
Icahn Onshore LP
Icahn Offshore LP
Icahn Capital L.P.
IPH GP LLC
Icahn Enterprises Holdings L.P.
Icahn Enterprises G.P. Inc.
Beckton Corp.
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (check the appropriate box):
[X] No fee required.
[ ] Fee computed on table below per Exchange Act Rule 14a-6(i)(4) and 0-11.
1) Title of each class of securities to which transaction applies:
2) Aggregate number of securities to which transaction applies:
3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
4) Proposed maximum aggregate value of transaction:
5) Total fee paid:
[ ] Fee paid previously with preliminary materials.
[ ] Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its filing.
1) Amount Previously Paid:
2) Form, Schedule or Registration Statement No.:
3) Filing Party:
4) Date Filed:
ON JULY 19, 2011, THE PARTICIPANTS (AS DEFINED BELOW) FILED A DEFINITIVE PROXY
STATEMENT WITH THE SECURITIES AND EXCHANGE COMMISSION. SECURITY HOLDERS ARE
ADVISED TO READ THE DEFINITIVE PROXY STATEMENT AND OTHER DOCUMENTS RELATED TO
THE SOLICITATION OF PROXIES BY CARL C. ICAHN, DR. ALEXANDER J. DENNER, DR.
RICHARD MULLIGAN, PROFESSOR LUCIAN A. BEBCHUK, DR. ERIC J. ENDE, MAYU SRIS,
ICAHN PARTNERS LP, ICAHN PARTNERS MASTER FUND LP, ICAHN PARTNERS MASTER FUND II
L.P., ICAHN PARTNERS MASTER FUND III L.P., HIGH RIVER LIMITED PARTNERHIP, HOPPER
INVESTMENTS LLC, BARBERRY CORP., ICAHN ENTERPRISES G.P. INC., ICAHN ENTERPRISES
HOLDINGS L.P., IPH GP LLC, ICAHN CAPITAL L.P., ICAHN ONSHORE LP, ICAHN OFFSHORE
LP, AND BECKTON CORP. (COLLECTIVELY, THE "PARTICIPANTS") FROM THE STOCKHOLDERS
OF FOREST LABORATORIES, INC. FOR USE AT ITS 2011 ANNUAL MEETING OF STOCKHOLDERS,
BECAUSE THEY CONTAIN IMPORTANT INFORMATION, INCLUDING INFORMATION RELATING TO
THE PARTICIPANTS. THE DEFINITIVE PROXY STATEMENT AND A FORM OF PROXY IS
AVAILABLE TO STOCKHOLDERS OF FOREST LABORATORIES, INC. FROM THE PARTICIPANTS AT
NO CHARGE AND IS ALSO AVAILABLE AT NO CHARGE AT THE SECURITIES AND EXCHANGE
COMMISSION'S WEBSITE AT HTTP://WWW.SEC.GOV OR BY CONTACTING D.F. KING & CO.,
INC. BY TELEPHONE AT THE FOLLOWING NUMBERS: STOCKHOLDERS CALL TOLLFREE: (800)
697-6975 AND BANKS AND BROKERAGE FIRMS CALL: (212) 269-5550.
FOR IMMEDIATE RELEASE
COURT ORDERS FOREST LABORATORIES TO RELEASE DOCUMENTS
RELATING TO SOLOMON EXCLUSION
HHS Initially Sought to Exclude 8 Top Executives
Released Board Minutes Reveal Flawed Board Process
New York, New York - August 5, 2011 - The Icahn Group announced today that the
Delaware Chancery Court ordered Forest Laboratories to release documents
relating to the current action by the Office of the Inspector General of the
U.S. Department of Health and Human Services that could exclude Howard Solomon
from participating in federal healthcare programs. The Icahn Group is seeking to
have its 4 nominees elected to the 10 person Board of Directors of Forest Labs
at its 2011 annual meeting of stockholders to be held on August 18, 2011.
Among the information released is a letter from Forest Labs' counsel to the OIG
which indicates that the OIG had initially contemplated bringing an exclusion
proceeding against not only Howard Solomon but EIGHT top executives of Forest.
According to this letter, Forest was made aware of this possibility on or prior
to September 2010. THAT MEANS THAT NEARLY ONE YEAR AGO, FOREST WAS FACED WITH A
THREAT TO THE CONTINUITY OF ITS MANAGEMENT TEAM AND TODAY STILL HAS NOT
DISCLOSED A VIABLE, OR EVEN ANY, SUCCESSION PLAN. In fact, Forest has yet to
fill the vacancy in its top operations role created by Mr. Olanoff's resignation
in December 2010. This is unacceptable.
In addition, the released information contains minutes of a Board meeting held
on April 5, 2011, at which (1) the Directors were FIRST informed that the OIG
was considering excluding Mr. Solomon and (2) the Directors promptly determined
to have the Company support, and pay for, Solomon's fight against the OIG.
DISTURBINGLY, THE MINUTES SHOW THAT MR. SOLOMON WAS PRESENT DURING THE ENTIRE
MEETING WHERE HIS EXCLUSION WAS BEING DISCUSSED AND VOTED ON! We believe that
his presence, among other things, flawed the Board's process. No special
committee of independent directors was established, even though a majority of
the Board members present at that meeting were affiliated inside directors per
ISS standards. Those directors that were independent by those standards did not
even meet in executive session. Instead, Solomon was present during all
deliberations and during the actual voting. He merely recused himself from
voting. Moreover, most of the presentations and recommendations during that
meeting were made by Herschel Weinstein, the Company's General Counsel, and by
senior management which recommended that the Company take "all reasonable steps
to avoid the issuance of an exclusion order and, if one is issued, to enjoin its
enforcement."
The Icahn Group believes this is symptomatic of larger governance problems at
Forest Labs. Our Delaware counsel advised us that good corporate governance
would have required that Mr. Solomon and the other insiders not be present at
that meeting so that the directors could engage in a free and open discourse on
the subject and be able to ultimately cast their vote without being concerned
about repercussions resulting from the longtime Chairman and CEO of the Company,
the target of the OIG action at issue, listening to their views and watching how
they voted. They should have been afforded the opportunity to consult with, and
be advised by, their own legal advisors. And perhaps they should have taken more
time to make a reasonable, thoughtful and fully informed decision. We believe
that the minutes paint a picture of a controlled and conflicted board being
steered into making a seemingly hasty decision by Solomon and the rest of senior
management.
Equally alarming, nowhere in the Board minutes provided to us is there any
indication that, in making its decision, the Board considered a contingency plan
in the event of an unfavorable outcome with the OIG. According to the minutes,
Mr. Weinstein indicated to the Board that if the OIG successfully excluded Mr.
Solomon, he would be required to resign as a director and an officer within 20
days and that implementing a transition in that time frame could be disruptive
and detrimental to the Company. This also suggests that the Company has no plan
to deal with the contingency of Mr. Solomon's exclusion. That the directors
would cause the Company to embark on such a precarious path without a safety net
raises significant issues as to whether the Board complied with its duty of
care. It is noteworthy that none of the materials provided to us by the Company
on July 20, 2011 indicate how the Company would deal with the possibility of Mr.
Solomon's exclusion. Yet on July 28, 2011, the Company disclosed to the
stockholders as part of this proxy contest that the "Board of Directors
contingency plan assures [that the] dispute [with the OIG] will have no impact
on the Company's ability to do business with the federal government."
BUSINESS AS USUAL IS NO LONGER AN OPTION. FOREST IS AT A CRITICAL JUNCTURE. WE
DO NOT BELIEVE THAT THE BOARD IS CAPABLE OF SUCCESSFULLY NAVIGATING THE COMPANY
THROUGH ITS IMMINENT CHALLENGES. WE BELIEVE THAT FOREST LABS NEEDS THE
INDEPENDENCE AND EXPERIENCE OF THE ICAHN NOMINEES TO HELP FACE THESE CHALLENGES
SUCCESSFULLY.
We urge stockholders to vote the GOLD proxy card FOR Dr. Denner, Dr. Mulligan,
Prof. Bebchuk and Dr. Ende. Stockholders should be advised that they CANNOT use
the WHITE proxy card to vote for any of Dr. Denner, Dr. Mulligan, Prof. Bebchuk
or Dr. Ende. Please use the GOLD proxy card to support our nominees.
If any stockholder has any questions about voting its shares, please call Edward
McCarthy of D.F. King & Co., Inc., at (212) 269-5550.
ON JULY 19, 2011, THE PARTICIPANTS (AS DEFINED BELOW) FILED A DEFINITIVE PROXY
STATEMENT WITH THE SECURITIES AND EXCHANGE COMMISSION. SECURITY HOLDERS ARE
ADVISED TO READ THE DEFINITIVE PROXY STATEMENT AND OTHER DOCUMENTS RELATED TO
THE SOLICITATION OF PROXIES BY CARL C. ICAHN, DR. ALEXANDER J. DENNER, DR.
RICHARD MULLIGAN, PROFESSOR LUCIAN A. BEBCHUK, DR. ERIC J. ENDE, MAYU SRIS,
ICAHN PARTNERS LP, ICAHN PARTNERS MASTER FUND LP, ICAHN PARTNERS MASTER FUND II
L.P., ICAHN PARTNERS MASTER FUND III L.P., HIGH RIVER LIMITED PARTNERHIP, HOPPER
INVESTMENTS LLC, BARBERRY CORP., ICAHN ENTERPRISES G.P. INC., ICAHN ENTERPRISES
HOLDINGS L.P., IPH GP LLC, ICAHN CAPITAL L.P., ICAHN ONSHORE LP, ICAHN OFFSHORE
LP, AND BECKTON CORP. (COLLECTIVELY, THE "PARTICIPANTS") FROM THE STOCKHOLDERS
OF FOREST LABORATORIES, INC. FOR USE AT ITS 2011 ANNUAL MEETING OF STOCKHOLDERS,
BECAUSE THEY CONTAIN IMPORTANT INFORMATION, INCLUDING INFORMATION RELATING TO
THE PARTICIPANTS. THE DEFINITIVE PROXY STATEMENT AND A FORM OF PROXY IS
AVAILABLE TO STOCKHOLDERS OF FOREST LABORATORIES, INC. FROM THE PARTICIPANTS AT
NO CHARGE AND IS ALSO AVAILABLE AT NO CHARGE AT THE SECURITIES AND EXCHANGE
COMMISSION'S WEBSITE AT HTTP://WWW.SEC.GOV OR BY CONTACTING D.F. KING & CO.,
INC. BY TELEPHONE AT THE FOLLOWING NUMBERS: STOCKHOLDERS CALL TOLLFREE: (800)
697-6975 AND BANKS AND BROKERAGE FIRMS CALL: (212) 269-5550.
Contact: Susan Gordon (212) 702-4309
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jul 2023 to Jul 2024